Quantcast
Last updated on April 19, 2014 at 18:42 EDT

Latest Vaccination Stories

2014-03-04 08:30:53

LOS ANGELES, March 4, 2014 /PRNewswire/ -- ImmunoCellular Therapeutics, Ltd. ("ImmunoCellular") (NYSE MKT: IMUC) today announced that it plans to report fourth quarter and full year 2013 financial results on Thursday, March 13, 2014. ImmunoCellular will host a conference call and webcast to discuss its financial results and provide a business update at 5:00 pm ET that day. The call will be hosted by Andrew Gengos, President and CEO....

2014-03-03 00:21:43

LYON, France, March 3, 2014 /PRNewswire/ -- - Sanofi Pasteur works with global partners to make available unparalleled quantities of affordable Inactivated Polio Vaccine (IPV) - Sanofi Pasteur, the vaccines division of Sanofi (EURONEXT: SAN and NYSE: SNY), announced today its further commitment to the international community's efforts to complete polio eradication. UNICEF, the organization that procures the vaccine to meet global needs, announced...

2014-02-28 14:04:34

Findings May Help Make Immunizations More Effective Somali Americans develop twice the antibody response to rubella from the current vaccine compared to Caucasians in a new Mayo Clinic study on individualized aspects of immune response. A non-Somali, African-American cohort ranked next in immune response, still significantly higher than Caucasians, and Hispanic Americans in the study were least responsive to the vaccine. The findings appear in the journal Vaccine. “This is...

2014-02-28 12:27:36

Dr. Brian Hooker, PhD, says Forbes misrepresented congressional record and CDC studies CHARLOTTE, N.C., Feb. 28, 2014 /PRNewswire-iReach/ -- Last week, PhD biochemist Brian Hooker created a stir when he announced he had obtained sensitive documents from the CDC (Centers for Disease Control and Prevention) through Freedom of Information Act (FOIA) requests. According to Hooker, these documents implicated the vaccine preservative Thimerosal (50% mercury by weight) in causing autism...

2014-02-27 12:27:13

bioCSL Inc. initiates 2014-15 season pre-booking for AFLURIA® (Influenza Vaccine) KING OF PRUSSIA, Pa., Feb. 27, 2014 /PRNewswire/ -- CSL Biotherapies Inc. announced today it has changed its name to bioCSL Inc., effective February 21, 2014. This change is pursuant to the Australian, New Zealand and German renaming of the company, which occurred one year ago. In September 2013, bioCSL was the first United States supplier to complete its 2013-14 seasonal influenza vaccine delivery...

Self-administration Of Flu Vaccine With A Patch May Be Possible
2014-02-27 08:47:47

John Toon, Georgia Institute of Technology The annual ritual of visiting a doctor's office or health clinic to receive a flu shot may soon be outdated, thanks to the findings of a new study published in the journal Vaccine. The research, which involved nearly 100 people recruited in the metropolitan Atlanta area, found that test subjects could successfully apply a prototype vaccine patch to themselves. That suggests the self-administration of vaccines with microneedle patches may one...

2014-02-26 20:22:18

DUBLIN, February 26, 2014 /PRNewswire/ -- Dublin - Research and Markets ( http://www.researchandmarkets.com/research/h27svw/flatrate) has announced the addition of the "Flat-Rate Subscription to In-Depth Publishing Reports on Oncology, Biosimilars, Antibodies, Proteins and Vaccines" [http://www.researchandmarkets.com/research/h27svw/flatrate ] subscription to their offering. (Logo: http://photos.prnewswire.com/prnh/20130307/600769 ) Subscription to this product...

2014-02-26 16:28:53

BLUE BELL, Pa., Feb. 26, 2014 /PRNewswire/ -- Inovio Pharmaceuticals, Inc. (NYSE MKT: INO) ("Inovio" or the "Company"), today announced that it intends to offer and sell shares of its common stock in an underwritten public offering. Piper Jaffray & Co. and Stifel, Nicolaus & Company, Incorporated are acting as joint bookrunning managers for the offering. The offering is subject to market conditions, and there can be no assurance as to whether or when the offering may be...

Anti-Vaccine Conspiracy Theories May Lower Vaccination Rate
2014-02-26 09:39:35

Rebekah Eliason for redOrbit.com – Your Universe Online Within an hour of birth it is suggested that children receive their first vaccinations. Interestingly, many people balk at the idea of vaccinating their infants and children due to an overwhelming amount of anti-vaccine conspiracy theories. These rumors often fill parents with fear when it comes time for the nurse to shove the dreaded needle into their little one. However, many people attaching to these theories forget the...

2014-02-25 20:21:36

DUBLIN, February 26, 2014 /PRNewswire/ -- Research and Markets ( http://www.researchandmarkets.com/research/jnwqq6/h1n1_vaccines) has announced the addition of the "H1N1 Vaccines - Global Strategic Business Report" [http://www.researchandmarkets.com/research/jnwqq6/h1n1_vaccines ] report to their offering. (Logo: http://photos.prnewswire.com/prnh/20130307/600769 ) This report analyzes the Global market for H1N1 Vaccines in US$ Million. The report provides...


Latest Vaccination Reference Libraries

0_ac8af9115d7f37daaaa2af4dba273fb1
2011-01-11 14:17:29

The Cowpox virus causes a skin disease known as cowpox. It is related to the vaccinia virus and gained its name because it spread by dairymaids touching the udders of infected cows. It manifests as red blisters. It is similar to smallpox although much milder and was actually the basis of the first smallpox vaccine. A person who recovers from cowpox is immune to smallpox. In 1980 the World Health Organization announced that smallpox was the first disease to be eradicated world wide by a...

More Articles (1 articles) »